22 September 2024
Welcoming New Editorial Board Members of Cancers
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that five new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694) in 2024. We wish our new members success in both their research and the efforts to develop the journal.

Name: Dr. Arpad Szallasi
Affiliation: Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Interests: the capsaicin (vanilloid) receptor TRPV1; “thermoTRP” expression in cancer; TRP channels as oncotargets; TRP channels as tumor suppressors; sensory nerve–tumor interactions; oncothermia

Name: Dr. Biplab Dasgupta
Affiliation: Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
Interests: cancer metabolism; brain tumors; cancer development

Name: Prof. Dr. David Eisenstat
Affiliations:
1Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia; 2Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia; 3Neuro-Oncology Laboratory, Murdoch Children's Research Institute, Parkville, VIC, Australia.
Interests: brain tumors; gliomas; transcription factors; brain development; clinical trials; biomarkers; hypoxia; homeobox genes; epigenetics; pediatric cancers

Name: Dr. Emiliano Cocco
Affiliation: Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Interests: tumor biology; rare oncogenic drivers; mechanisms of resistance to therapy

Name: Prof. Dr. Eva Compérat
Affiliation: Department of Pathology, General Hospital, Medical University Vienna, 1090 Vienna, Austria
Interests: uropathology; development of bladder cancer; prostate cancer
Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.
Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office and provide the following files: